I have previously blogged about the tremendous success of the Global Programme to Eliminate Lymphatic Filariasis. This week’s BMJ has even more evidence to support this view.
In just over a decade, the GPELF has now successfully eliminated LF in 16 countries. Many of the countries are those pretty to easy to conquer island nations of the South Pacific, but some African countries have made the list, including Togo – a small country – but a country I can attest first hand comes with its own set of challenges.
You can read more about these successes here.
Kudos need to go out to the partnership, but I think especially to the pharmaceutical companies that have made this possible: GlaxoSmithKline, which provides albendazole, and Merck, which provides ivermectin. Both companies have been long-term partners to global health, both have made long-term commitments, and both have given their products completely free of charge.Share on Facebook